Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...

Analyst Jonathan Wolleben from JMP Securities reiterated a Buy rating on DBV Technologies SA – American (DBVT – Research Report) and keeping ...

JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of ...

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Alphabet, Inc. ($GOOGL) ($GOOG) shares, which witnessed accelerating upward momentum in late 2024, snagged a rating downgrade ...

StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research report report published on Wednesday. The brokerage issued a hold rating on the stock. DBVT has ...

CEO Krishna Vaddi purchased 10,000 shares of Prelude Therapeutics stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average price of $1.20 per share, for a ...

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Free Report) saw strong trading volume on Friday . 624,936 shares were traded during trading, an increase of 12% from the previous session’s volume ...

StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the stock. Several other ...

Growing eSIM support on South African mobile networks and more affordable eSIM-capable devices are making it feasible for ...

My subscription has now lapsed and I have no plans to renew it, even with my new credit card. Let that be a lesson for you ...